Vitaliti Technologies is at the forefront of the massive global shift toward proactive, continuous care. Backed by strategic funding—including support from the Ontario government's Life Sciences Scale-Up Fund—Vitaliti is rapidly scaling manufacturing capabilities at our Kitchener, ON facility to meet surging B2B and B2G demand.
While advancing toward final regulatory clearances, Vitaliti has established immediate commercial viability by serving the lucrative medical research and provincial health markets. In 2024 alone, we secured 7 contracts valued in excess of $2.5 million CAD, including a massive 300-unit, $770,000 CAD deployment for multi-site post-operative monitoring.
We are systematically de-risking our technology through rigorous validation. The ongoing VERDICT-2 trial and our multi-site post-operative RPM deployments are actively generating the clinical evidence required for our upcoming Health Canada license and FDA clearance submissions.
Thank you for your interest in learning more about our opportunities. Please fill out the form below to request additional information or a copy of our investor presentation. We’re excited to connect and provide you with the details you need to explore this exciting investment opportunity.